CLOVIS ONCOLOGY INC's ticker is and the CUSIP is 189464AC4. A total of 18 filers reported holding CLOVIS ONCOLOGY INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $29,537,000 | -0.0% | 42,200,000 | 0.0% | 0.01% | +10.0% |
Q2 2022 | $29,540,000 | -6.7% | 42,200,000 | 0.0% | 0.01% | +11.1% |
Q1 2022 | $31,651,000 | +7.9% | 42,200,000 | 0.0% | 0.01% | +12.5% |
Q4 2021 | $29,333,000 | -3.6% | 42,200,000 | 0.0% | 0.01% | -20.0% |
Q3 2021 | $30,438,000 | -1.6% | 42,200,000 | 0.0% | 0.01% | 0.0% |
Q2 2021 | $30,948,000 | -2.9% | 42,200,000 | 0.0% | 0.01% | -9.1% |
Q1 2021 | $31,887,000 | +9.5% | 42,200,000 | +0.5% | 0.01% | +10.0% |
Q4 2020 | $29,131,000 | -0.9% | 42,000,000 | 0.0% | 0.01% | -16.7% |
Q3 2020 | $29,395,000 | +15.6% | 42,000,000 | 0.0% | 0.01% | +9.1% |
Q2 2020 | $25,430,000 | +10.3% | 42,000,000 | +7.7% | 0.01% | -8.3% |
Q1 2020 | $23,047,000 | +5.7% | 39,000,000 | +12.2% | 0.01% | +33.3% |
Q4 2019 | $21,806,000 | +60.6% | 34,750,000 | +6.9% | 0.01% | +50.0% |
Q3 2019 | $13,582,000 | -34.8% | 32,500,000 | -3.0% | 0.01% | -33.3% |
Q2 2019 | $20,841,000 | -12.4% | 33,500,000 | +9.8% | 0.01% | -18.2% |
Q1 2019 | $23,785,000 | +26.8% | 30,500,000 | +13.8% | 0.01% | +22.2% |
Q4 2018 | $18,756,000 | +17.8% | 26,800,000 | +30.1% | 0.01% | +50.0% |
Q3 2018 | $15,923,000 | -9.0% | 20,600,000 | +8.4% | 0.01% | -25.0% |
Q2 2018 | $17,497,000 | – | 19,000,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|